Aby J. Mathew serves as the Executive Vice President and Chief Scientific Officer at BIOLIFE SOLUTIONS INC, a leading developer and supplier of bioproduction tools and services for the cell and gene therapy industry. In his role, Mathew is responsible for overseeing the company's scientific strategy and advancing its portfolio of innovative products and solutions that enable the storage, shipping, and clinical use of cell and gene therapies. His leadership has been instrumental in driving BIOLIFE SOLUTIONS INC's growth and establishing the company as a trusted partner in the rapidly evolving field of regenerative medicine. Prior to joining BIOLIFE SOLUTIONS INC, Mathew held various leadership positions in the life sciences industry, where he gained extensive experience in bioprocessing, biopreservation, and the development of cell-based therapies. He has a proven track record of successfully bringing new products to market and collaborating with key opinion leaders to advance scientific knowledge and improve patient outcomes. Mathew's expertise in the field, coupled with his strategic vision, has enabled him to make significant contributions to the company's success and its mission to accelerate the delivery of life-saving cell and gene therapies to patients worldwide. As a respected thought leader in the industry, Mathew is frequently invited to speak at conferences and contribute to scientific publications. He holds a Ph.D. in Biomedical Engineering from the University of California, San Diego, and has authored numerous peer-reviewed articles on topics related to biopreservation and cell therapy. Under his guidance, BIOLIFE SOLUTIONS INC continues to push the boundaries of what is possible in the field of regenerative medicine, working closely with its customers to develop customized solutions that meet their unique needs and help bring transformative therapies to market faster.